Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice

Toxicological Sciences

Volumn 109, Issue 1, 2009, Pages 106-112

  Dewitt, Jamie C ^a   Copeland, Carey B ^b   Luebke, Robert W ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Corticosterone; Immunotoxicity; Perfluoronated agents

Indexed keywords

CORTICOSTERONE; DRINKING WATER; IMMUNOGLOBULIN M ANTIBODY; PERFLUOROOCTANOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEMALE; HORMONE SYNTHESIS; HUMORAL IMMUNITY; IMMUNOTOXICITY; LYMPHOID ORGAN; MOUSE; NONHUMAN; ORGAN WEIGHT; T LYMPHOCYTE;

ADRENALECTOMY; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODY FORMATION; BLOOD CHEMICAL ANALYSIS; BODY WEIGHT; CORTICOSTERONE; FEMALE; FLUOROCARBONS; IMMUNE TOLERANCE; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED C57BL; OCTANOIC ACIDS;

ANIMALIA; MUS;

EID: 64949085671     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfp040     Document Type: Article

References (21)

1. DeWitt, J. C., Copeland, C. B., and Luebke, R. W. (2005). Immune responses in Sprague-Dawley rats exposed to dibutyltin dichloride in drinking water as adults. J. Immunotoxicol. 2, 151-160.
2. DeWitt, J. C., Copeland, C. B., Strynar, M. J., and Luebke, R. W. (2008). Perfluorooctanoic acid-induced immunomodulation in adult C57BL/ 6J or C57Bl/6N female mice. Environ. Health Perspect. 116, 644-650.
3. Fang, X., Zhang, L., Feng, Y., Zhao, Y., and Dai, J. (2008). Immunotoxic effects of perfluorononanoic acid on BALB/c mice. Toxicol. Sci. 105, 312-321.
4. Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., and Farrar, D. G. (2004). The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 34, 351-384.
5. Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., and Seed, J. (2007). Perfluoroalkyl acids: A review of monitoring and toxicological findings. Toxicol. Sci. 99, 366-394.
6. Loveless, S. E., Hoban, D., Sykes, G., Frame, S. R., and Everds, N. E. (2008). Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate. Toxicol. Sci. 105, 86-96.
7. Neigh, G. N., Bowers, S. L., Pyter, L. M., Gatien, M. L., and Nelson, R. J. (2004). Pyruvate prevents restraint-induced immunosuppression via alterations in glucocorticoid responses. Endocrinology 145, 4309-4319.
8. Peden-Adams, M. M., Keller, J. M., EuDaly, J. G., Berger, J., Gilkeson, G. S., and Keil, D. E. (2008). Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol. Sci. 104, 144-154.
9. Pruessner, J. C., Kirschbaum, C., Meinlschmid, G., and Hellhammer, D. K. (2003). Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28, 916-931.
10. Pruett, S. B. (2001). Quantitative aspects of stress-induced immunomodulation. Int. Immunopharmacol. 1, 507-520.
11. Pruett, S. B. (2003). Stress and the immune system. Pathophysiology 9, 133-153.
12. Pruett, S. B., Collier, S., Wu, W.-J., and Fan, R. (1999). Quantitative relationships between the suppression of selected immunological parameters and the area under the corticosterone concentration vs. time curve in B6C3F1 mice subjected to exogenous corticosterone or to restraint stress. Toxicol. Sci. 49, 272-280.
13. Pruett, S. B., and Fan, R. (2001). Quantitative modeling of suppression of IgG1, IgG2a, IL-2, and IL-4 responses to antigen in mice treated with exogenous corticosterone or restraint stress. J. Toxicol. Environ. Health A. 62, 175-189.
14. Pruett, S. B., Fan, R., Zheng, Q., Myers, L. P., and Hébert, P. (2003). Modeling and predicting immunological effects of chemical stressors: Characterization of a quantitative biomarker for immunological changes caused by atrazine and ethanol. Toxicol. Sci. 75, 343-354.
15. Pruett, S., and Hébert, P. (2007). Characterization of the action of drug-induced stress responses on the immune system: Evaluation of biomarkers for drug-induced stress in rats. J. Immunotoxicol. 4 25-38.
16. Taylor, B. K., Dadia, N., Yang, C. B., Krishnan, S., and Badr, M. (2002). Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia. Inflammation 26, 121-127.
17. Taylor, B. K., Kriedt, C., Nagalingam, S., Dadia, N., and Badr, M. (2005). Central administration of perfluorooctanoic acid inhibits cutaneous inflammation. Inflamm. Res. 54, 235-242.
18. Temple, L., Butterworth, T. T., Kawabata, A. E., Munson, A. E., and White, K. L., Jr. (1995). ELISA to measure SRBC specific serum IgM: method and data evaluation. In Methods in Immunology (G. R. Burleson, J. H. Dean, and A. E. Munson, Eds.), pp. 137-157. Wiley-Liss, Inc., New York.
19. Yang, Q., Abedi-Valugerdi, M., Xie, Y., Zhao, X. Y., Moller, G., Nelson, B. D., and DePierre, J. W. (2002). Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int. Immunopharmacol. 2 389-397.
20. Yang, Q., Xie, Y., and Depierre, J. W. (2000). Effects of peroxisome proliferators on the thymus and spleen of mice. Clin. Exp. Immunol. 122, 219-226.
21. Yang, Q., Xie, Y., Eriksson, A. M., Nelson, B. D., and DePierre, J. W. (2001). Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. Biochem. Pharmacol. 62, 1133-1140.